KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for TherapeuticsMD (TXMD) over the last 9 years, with Sep 2025 value amounting to -0.05%.

  • TherapeuticsMD's Return on Capital Employed rose 15.00% to -0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05%, marking a year-over-year increase of 15.00%. This contributed to the annual value of -0.13% for FY2024, which is 1.00% up from last year.
  • Per TherapeuticsMD's latest filing, its Return on Capital Employed stood at -0.05% for Q3 2025, which was up 13.43% from -0.06% recorded in Q2 2025.
  • TherapeuticsMD's Return on Capital Employed's 5-year high stood at 4.47% during Q2 2022, with a 5-year trough of -1.12% in Q3 2021.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.12% (2025), whereas its average is 0.08%.
  • Per our database at Business Quant, TherapeuticsMD's Return on Capital Employed spiked by 530bps in 2022 and then plummeted by 378bps in 2023.
  • Over the past 5 years, TherapeuticsMD's Return on Capital Employed (Quarterly) stood at 2.21% in 2021, then crashed by 219bps to 0.02% in 2022, then decreased by 23bps to -0.21% in 2023, then increased by 8bps to -0.13% in 2024, then increased by 15bps to -0.05% in 2025.
  • Its Return on Capital Employed stands at -0.05% for Q3 2025, versus -0.06% for Q2 2025 and -0.12% for Q1 2025.